Background Patients with alopecia areata (AA) report a broad range of psychosocial outcomes
beyond those assessed in existing health-related quality of life measures. Yet, to date, no …

… The mean time until response was 3.8 months (range 1–6) and the mean duration of
response was 4.8 months (range 0–36). Adverse side effects from the medication used were …

… Genetic factors have been implicated with the reports of familial incidence of AA in a range
… [42] and a Gaussian distribution of severity that ranges from patchy localized hair loss on the …

Objective To provide family physicians with a background understanding of the therapeutic
regimens and treatment outcomes for alopecia areata (AA), as well as to help identify those …

… alopecia areata than in alopecia totalis/alopecia universalis. Therapy for alopecia areata …
review discusses the therapeutic options and management strategies for alopecia areata. …

… associated with vaccination was in the normal, predicted incidence range 102 . … that are
necessary for the development and full progression of alopecia areata. The 1MOG244.1 T cell …

… Alopecia areata is a form of autoimmune hair loss with a lifetime prevalence of approximately
2%. A personal or family history of concomitant autoimmune disorders, such as vitiligo or …

… A range of systemic treatments are used for alopecia areata … for alopecia areata, alopecia
totalis and alopecia universalis. … treatments for individuals with alopecia areata, totalis or …

… Alopecia areata (AA) is a common, non-scarring dermatologic condition regularly … forms,
including alopecia totalis (total loss of hair on the scalp) and alopecia universalis (complete loss …

… The age range of the patients was 2 to 69 years (mean 29.2 … of the National Alopecia Areata
Foundation guidelines14, 15: S … loss, alopecia totalis (AT); S 5 B 2 : total scalp and body hair, …